Expression and function of dopamine receptors in the developing medial frontal cortex and striatum of the rat

Neuroscience

Volumn 199, Issue , 2011, Pages 501-514

  Daws, S E ^a   Konradi, C ^a,b  

^a VANDERBILT UNIVERSITY   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Dopamine receptors; Medial frontal cortex; Prenatal brain development; Primary neuronal culture; QPCR; Striatum

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; GLYCOGEN SYNTHASE KINASE 3BETA; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN DEVELOPMENT; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; EMBRYO; EMBRYO DEVELOPMENT; ENZYME ACTIVATION; FEMALE; GENE EXPRESSION; GENE MAPPING; IN SITU HYBRIDIZATION; MEDIAL FRONTAL CORTEX; NERVE CELL CULTURE; NERVE CELL NETWORK; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRENATAL DEVELOPMENT; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RAT; RECEPTOR DENSITY; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; TISSUE SPECIFICITY;

EID: 83055176456     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2011.10.004     Document Type: Article

References (60)

1. Aldridge G.M., Podrebarac D.M., Greenough W.T., Weiler I.J. The use of total protein stains as loading controls: an alternative to high-abundance single-protein controls in semi-quantitative immunoblotting. J Neurosci Methods 2008, 172:250-254.
2. Araki K.Y., Sims J.R., Bhide P.G. Dopamine receptor mRNA and protein expression in the mouse corpus striatum and cerebral cortex during pre- and postnatal development. Brain Res 2007, 1156:31-45.
3. Arnsten A.F., Li B.M. Neurobiology of executive functions: catecholamine influences on prefrontal cortical functions. Biol Psychiatry 2005, 57:1377-1384.
4. Bahi A., Dreyer J.L. Cocaine-induced expression changes of axon guidance molecules in the adult rat brain. Mol Cell Neurosci 2005, 28:275-291.
5. Barzilai A., Melamed E. Molecular mechanisms of selective dopaminergic neuronal death in Parkinson's disease. Trends Mol Med 2003, 9:126-132.
6. Beaulieu J.M., Gainetdinov R.R. The physiology, signaling, and pharmacology of dopamine receptors. Pharmacol Rev 2011, 63:182-217.
7. Beaulieu J.M., Gainetdinov R.R., Caron M.G. Akt/GSK3 signaling in the action of psychotropic drugs. Annu Rev Pharmacol Toxicol 2009, 49:327-347.
8. Beaulieu J.M., Tirotta E., Sotnikova T.D., Masri B., Salahpour A., Gainetdinov R.R., Borrelli E., Caron M.G. Regulation of Akt signaling by D2 and D3 dopamine receptors in vivo. J Neurosci 2007, 27:881-885.
9. Benjamini Y., Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B Stat Methodol 1995, 57:289-300.
10. Berger B., Verney C., Gay M., Vigny A. Immunocytochemical characterization of the dopaminergic and noradrenergic innervation of the rat neocortex during early ontogeny. Prog Brain Res 1983, 58:263-267.
11. Bertran-Gonzalez J., Bosch C., Maroteaux M., Matamales M., Hervé D., Valjent E., Girault J.A. Opposing patterns of signaling activation in dopamine D1 and D2 receptor-expressing striatal neurons in response to cocaine and haloperidol. J Neurosci 2008, 28:5671-5685.
12. Bonnin A., Torii M., Wang L., Rakic P., Levitt P. Serotonin modulates the response of embryonic thalamocortical axons to netrin-1. Nat Neurosci 2007, 10:588-597.
13. Bouchard J.F., Moore S.W., Tritsch N.X., Roux P.P., Shekarabi M., Barker P.A., Kennedy T.E. Protein kinase A activation promotes plasma membrane insertion of DCC from an intracellular pool: a novel mechanism regulating commissural axon extension. J Neurosci 2004, 24:3040-3050.
14. Brami-Cherrier K., Valjent E., Garcia M., Pagès C., Hipskind R.A., Caboche J. Dopamine induces a PI3-kinase-independent activation of Akt in striatal neurons: a new route to cAMP response element-binding protein phosphorylation. J Neurosci 2002, 22:8911-8921.
15. Bronson S.E., Konradi C. Second Messenger Cascades. Handbook of basal ganglia structure and function 2010, Vol. 20:447-460. Elsevier, Amsterdam. H. Steiner, K.Y. Tseng (Eds.).
16. Bunzow J.R., Van Tol H.H., Grandy D.K., Albert P., Salon J., Christie M., Machida C.A., Neve K.A., Civelli O. Cloning and expression of a rat D2 dopamine receptor cDNA. Nature 1988, 336:783-787.
17. Crandall J.E., McCarthy D.M., Araki K.Y., Sims J.R., Ren J.Q., Bhide P.G. Dopamine receptor activation modulates GABA neuron migration from the basal forebrain to the cerebral cortex. J Neurosci 2007, 27:3813-3822.
18. Cross D.A., Alessi D.R., Cohen P., Andjelkovich M., Hemmings B.A. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 1995, 378:785-789.
19. De Vries T.J., Mulder A.H., Schoffelmeer A.N. Differential ontogeny of functional dopamine and muscarinic receptors mediating presynaptic inhibition of neurotransmitter release and postsynaptic regulation of adenylate cyclase activity in rat striatum. Brain Res Dev Brain Res 1992, 66:91-96.
20. Dudman J.T., Eaton M.E., Rajadhyaksha A., Macías W., Taher M., Barczak A., Kameyama K., Huganir R., Konradi C. Dopamine D1 receptors mediate CREB phosphorylation via phosphorylation of the NMDA receptor at Ser897-NR1. J Neurochem 2003, 87:922-934.
21. Enjalbert A., Bockaert J. Pharmacological characterization of the D2 dopamine receptor negatively coupled with adenylate cyclase in rat anterior pituitary. Mol Pharmacol 1983, 23:576-584.
22. Genro J.P., Kieling C., Rohde L.A., Hutz M.H. Attention-deficit/hyperactivity disorder and the dopaminergic hypotheses. Expert Rev Neurother 2010, 10:587-601.
23. Girault J.A., Greengard P. The neurobiology of dopamine signaling. Arch Neurol 2004, 61:641-644.
24. Goto Y., Grace A.A. The dopamine system and the pathophysiology of schizophrenia: a basic science perspective. Int Rev Neurobiol 2007, 78:41-68.
25. Halladay A.K., Yue Y., Michna L., Widmer D.A., Wagner G.C., Zhou R. Regulation of EphB1 expression by dopamine signaling. Brain Res Mol Brain Res 2000, 85:171-178.
26. Iwakura Y., Nawa H., Sora I., Chao M.V. Dopamine D1 receptor-induced signaling through TrkB receptors in striatal neurons. J Biol Chem 2008, 283:15799-15806.
27. Jassen A.K., Yang H., Miller G.M., Calder E., Madras B.K. Receptor regulation of gene expression of axon guidance molecules: implications for adaptation. Mol Pharmacol 2006, 70:71-77.
28. Jung A.B., Bennett J.P. Development of striatal dopaminergic function. I. Pre- and postnatal development of mRNAs and binding sites for striatalD1 (D1a) and D2 (D2a) receptors. Brain Res Dev Brain Res 1996, 94:109-120.
29. Kalsbeek A., Voorn P., Buijs R.M., Pool C.W., Uylings H.B. Development of the dopaminergic innervation in the prefrontal cortex of the rat. J Comp Neurol 1988, 269:58-72.
30. Kauer J.A., Malenka R.C. Synaptic plasticity and addiction. Nat Rev Neurosci 2007, 8:844-858.
31. Konradi C., Leveque J.C., Hyman S.E. Amphetamine and dopamine-induced immediate early gene expression in striatal neurons depends on postsynaptic NMDA receptors and calcium. J Neurosci 1996, 16:4231-4239.
32. Kriegstein A., Noctor S., Martínez-Cerdeño V. Patterns of neural stem and progenitor cell division may underlie evolutionary cortical expansion. Nat Rev Neurosci 2006, 7:883-890.
33. Küppenbender K.D., Standaert D.G., Feuerstein T.J., Penney J.B., Young A.B., Landwehrmeyer G.B. Expression of NMDA receptor subunit mRNAs in neurochemically identified projection and interneurons in the human striatum. J Comp Neurol 2000, 419:407-421.
34. Marín O., Rubenstein J.L. A long, remarkable journey: tangential migration in the telencephalon. Nat Rev Neurosci 2001, 2:780-790.
35. McCurley A.T., Callard G.V. Characterization of housekeeping genes in zebrafish: male-female differences and effects of tissue type, developmental stage and chemical treatment. BMC Mol Biol 2008, 9:102.
36. Ming G.L., Song H.J., Berninger B., Holt C.E., Tessier-Lavigne M., Poo M.M. cAMP-dependent growth cone guidance by netrin-1. Neuron 1997, 19:1225-1235.
37. Neve K.A., Seamans J.K., Trantham-Davidson H. Dopamine receptor signaling. J Recept Signal Transduct Res 2004, 24:165-205.
38. Nishiyama M., Hoshino A., Tsai L., Henley J.R., Goshima Y., Tessier-Lavigne M., Poo M.M., Hong K. Cyclic AMP/GMP-dependent modulation of Ca2+ channels sets the polarity of nerve growth-cone turning. Nature 2003, 423:990-995.
39. Ohtani N., Goto T., Waeber C., Bhide P.G. Dopamine modulates cell cycle in the lateral ganglionic eminence. J Neurosci 2003, 23:2840-2850.
40. Popolo M., McCarthy D.M., Bhide P.G. Influence of dopamine on precursor cell proliferation and differentiation in the embryonic mouse telencephalon. Dev Neurosci 2004, 26:229-244.
41. Rajadhyaksha A., Barczak A., Macías W., Leveque J.C., Lewis S.E., Konradi C. L-Type Ca(2+) channels are essential for glutamate-mediated CREB phosphorylation and c-fos gene expression in striatal neurons. J Neurosci 1999, 19:6348-6359.
42. Rajadhyaksha A., Leveque J., Macías W., Barczak A., Konradi C. Molecular components of striatal plasticity: the various routes of cyclic AMP pathways. Dev Neurosci 1998, 20:204-215.
43. Sales N., Martres M.P., Bouthenet M.L., Schwartz J.C. Ontogeny of dopaminergic D-2 receptors in the rat nervous system: characterization and detailed autoradiographic mapping with [125I]iodosulpride. Neuroscience 1989, 28:673-700.
44. Schambra U.B., Duncan G.E., Breese G.R., Fornaretto M.G., Caron M.G., Fremeau R.T. Ontogeny of D1A and D2 dopamine receptor subtypes in rat brain using in situ hybridization and receptor binding. Neuroscience 1994, 62:65-85.
45. Schmidt U., Beyer C., Oestreicher A.B., Reisert I., Schilling K., Pilgrim C. Activation of dopaminergic D1 receptors promotes morphogenesis of developing striatal neurons. Neuroscience 1996, 74:453-460.
46. Seamans J.K., Yang C.R. The principal features and mechanisms of dopamine modulation in the prefrontal cortex. Prog Neurobiol 2004, 74:1-58.
47. Shi X., McGinty J.F. D1 and D2 dopamine receptors differentially mediate the activation of phosphoproteins in the striatum of amphetamine-sensitized rats. Psychopharmacol (Berl) 2011, 214:653-663.
48. Sillivan S.E., Black Y.D., Naydenov A.V., Vassoler F.M., Hanlin R.H., Konradi C. Binge cocaine administration in adolescent rats affects amygdalar gene expression patterns and alters anxiety-related behavior in adulthood. Biol Psychiatry 2011.
49. Song Z.M., Undie A.S., Koh P.O., Fang Y.Y., Zhang L., Dracheva S., Sealfon S.C., Lidow M.S. D1 dopamine receptor regulation of microtubule-associated protein-2 phosphorylation in developing cerebral cortical neurons. J Neurosci 2002, 22:6092-6105.
50. Souza B.R., Romano-Silva M.A., Tropepe V. Dopamine D2 receptor activity modulates Akt signaling and alters GABAergic neuron development and motor behavior in zebrafish larvae. J Neurosci 2011, 31:5512-5525.
51. Stanwood G.D., Washington R.A., Shumsky J.S., Levitt P. Prenatal cocaine exposure produces consistent developmental alterations in dopamine-rich regions of the cerebral cortex. Neuroscience 2001, 106:5-14.
52. Todd R.D. Neural development is regulated by classical neurotransmitters: dopamine D2 receptor stimulation enhances neurite outgrowth. Biol Psychiatry 1992, 31:794-807.
53. Valjent E., Corvol J.C., Pages C., Besson M.J., Maldonado R., Caboche J. Involvement of the extracellular signal-regulated kinase cascade for cocaine-rewarding properties. J Neurosci 2000, 20:8701-8709.
54. Van den Heuvel D.M., Pasterkamp R.J. Getting connected in the dopamine system. Prog Neurobiol 2008, 85:75-93.
55. Verney C., Berger B., Adrien J., Vigny A., Gay M. Development of the dopaminergic innervation of the rat cerebral cortex. A light microscopic immunocytochemical study using anti-tyrosine hydroxylase antibodies. Brain Res 1982, 281:41-52.
56. Yetnikoff L., Labelle-Dumais C., Flores C. Regulation of netrin-1 receptors by amphetamine in the adult brain. Neuroscience 2007, 150:764-773.
57. Zalesky A., Fornito A., Seal M.L., Cocchi L., Westin C.F., Bullmore E.T., Egan G.F., Pantelis C. Disrupted axonal fiber connectivity in schizophrenia. Biol Psychiatry 2011, 69:80-89.
58. Zhang L., Bai J., Undie A.S., Bergson C., Lidow M.S. D1 dopamine receptor regulation of the levels of the cell-cycle-controlling proteins, cyclin D, P27 and Raf-1, in cerebral cortical precursor cells is mediated through cAMP-independent pathways. Cereb Cortex 2005, 15:74-84.
59. Zhang L., Lidow M.S. D1 dopamine receptor regulation of cell cycle in FGF- and EGF-supported primary cultures of embryonic cerebral cortical precursor cells. Int J Dev Neurosci 2002, 20:593-606.
60. Zhou Q.Y., Grandy D.K., Thambi L., Kushner J.A., Van Tol H.H., Cone R., Pribnow D., Salon J., Bunzow J.R., Civelli O. Cloning and expression of human and rat D1 dopamine receptors. Nature 1990, 347:76-80.